We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

132 hedge funds and large institutions have $278M invested in Keryx Biopharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 15

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

6% more funds holding

Funds holding: 125 → 132 (+7)

0% less call options, than puts

Call options by funds: $2.21M | Put options by funds: $2.22M

11% less capital invested

Capital invested by funds: $313M → $278M (-$35.3M)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
3.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
38
Reduced
32
Closed
15
Calls
$2.21M
Puts
$2.22M
Net Calls
-$6K
Net Calls Change
+$1.92M

Top Buyers

Rank Fund Capital Flow
1
PIMJS
PKO Investment Management Joint-Stock
Poland
+$7.16M
2
Morgan Stanley
Morgan Stanley
New York
+$3.76M
3
BlackRock
BlackRock
New York
+$2.6M
4
OWIM
Old West Investment Management
California
+$2.16M
5
RHJA
Rice Hall James & Associates
California
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
CLM
ClearBridge LLC (Maryland)
Maryland
-$5.83M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.49M
3
State Street
State Street
Massachusetts
-$4.93M
4
Ameriprise
Ameriprise
Minnesota
-$3.95M
5
Goldman Sachs
Goldman Sachs
New York
-$3.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$97M – – –
ACM
2
Abrams Capital Management
Massachusetts
$37.4M +$1.12M +230,879 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$30.3M +$1.36M +278,315 +4%
BlackRock
4
BlackRock
New York
$24.9M +$2.6M +534,831 +9%
State Street
5
State Street
Massachusetts
$15.5M -$4.93M -1,013,536 -20%
RHJA
6
Rice Hall James & Associates
California
$8.56M +$1.76M +361,533 +19%
Norges Bank
7
Norges Bank
Norway
$7.71M – – –
PIMJS
8
PKO Investment Management Joint-Stock
Poland
$5.53M +$7.16M +1,469,609 New
Northern Trust
9
Northern Trust
Illinois
$4.48M +$470K +96,580 +9%
Morgan Stanley
10
Morgan Stanley
New York
$4.38M +$3.76M +771,315 +196%
OWIM
11
Old West Investment Management
California
$4.01M +$2.16M +444,415 +72%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$3.97M +$497K +102,014 +11%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$3.92M +$570K +117,168 +13%
Millennium Management
14
Millennium Management
New York
$2.73M -$1.04M -213,465 -23%
Charles Schwab
15
Charles Schwab
California
$2.07M +$62.2K +12,773 +2%
PPA
16
Parametric Portfolio Associates
Washington
$1.36M +$436K +89,528 +33%
Ameriprise
17
Ameriprise
Minnesota
$1.15M -$3.95M -811,186 -73%
Boston Partners
18
Boston Partners
Massachusetts
$1.1M +$178K +36,544 +14%
Bank of America
19
Bank of America
North Carolina
$1.1M +$520K +106,737 +58%
Deutsche Bank
20
Deutsche Bank
Germany
$1.07M -$94.3K -19,377 -6%
RA
21
Royce & Associates
New York
$965K – – –
TCIM
22
TIAA CREF Investment Management
New York
$760K -$12.2K -2,505 -1%
CEP
23
Chicago Equity Partners
Illinois
$747K – – –
William Blair & Company
24
William Blair & Company
Illinois
$733K +$33.1K +6,800 +4%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$684K -$72.1K -14,800 -8%
1
2 3 4 5

KERX Hedge Fund Activity: Q2 2018 in Review

132 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q2 2018, worth a combined $278M — down 11% from $313M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new KERX positions and 15 closed out — a net gain of 7 holders — while 38 added to existing stakes and 32 trimmed.

The largest buyer was PKO Investment Management Joint-Stock, opening a new position worth an estimated $7.16M. The largest seller was ClearBridge LLC (Maryland), cutting an estimated $5.83M.

  • 132 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q2 2018, up from 125 in Q1 2018.
  • Funds reported $278M of Keryx Biopharmaceuticals Inc stock for Q2 2018, down 11% quarter-over-quarter.
  • 22 funds opened new Keryx Biopharmaceuticals Inc positions in Q2 2018 and 15 closed out, a net change of +7 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q2 2018 was PKO Investment Management Joint-Stock, an estimated $7.16M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q2 2018 was ClearBridge LLC (Maryland), an estimated $5.83M sold.

Based on aggregated 13F filings for Q2 2018.